免疫不全と肝炎の60代男性
Caroline Hvitmyhr1, Kristin Fjeldstad Enga2, Joakim Øverbø3
1Medisinsk avdeling, Ringerike sykehus, Vestre Viken.
まとめ
免疫不全患者における肝酵素の上昇は、多様な感染症に起因する可能性があります。この集団におけるE型肝炎ウイルス(HEV)の診断には核酸検査が不可欠です。
科学分野:
- 肝臓学; 免疫学; 感染症学
背景:
- 肝酵素の上昇には、毒性、感染性、腫瘍性、自己免疫疾患など、複数の原因があります。; 免疫不全患者は、より広範な感染性肝炎病原体に、免疫応答が鈍麻しており、診断が複雑化しています。
研究 の 目的:
- 免疫不全患者における肝炎の診断上の課題を強調すること。; リスクのある集団におけるE型肝炎ウイルス(HEV)の特定の診断アプローチの重要性を強調すること。
主な方法:
- 多発性骨髄腫のCAR-T療法を受けている患者の症例提示。; 免疫不全患者における感染性肝炎の診断戦略の議論。
主要な成果:
- E型肝炎は、ノルウェーで感染する可能性のある、見過ごされがちな感染症です。; HEVの血清学的検査は、免疫不全患者では信頼性が低い場合があります。
結論:
- 免疫不全患者は、慢性E型肝炎のリスクが高まっています。; HEV RNAの核酸検査は、免疫不全患者におけるHEVの推奨される主要な診断アプローチです。
関連する概念動画
Immunodeficiency Diseases
2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.5K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System
6.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
248
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
248
Hepatic Drug Excretion: Influencing Factors
599
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
599
Hepatic Drug Clearance: Role of Transporters
311
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
311


